Christopher D. Maggiore - 12 Jun 2023 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)

Role
Director
Signature
/s/ Christopher D. Maggiore
Issuer symbol
ZIVO
Transactions as of
12 Jun 2023
Net transactions value
$0
Form type
4
Filing time
14 Jun 2023, 17:05:33 UTC
Previous filing
20 Dec 2022
Next filing
14 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Award $0 +21,756 $0.000000 21,756 12 Jun 2023 Common Stock 21,756 $2.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2024 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date.